期刊文献+

氯胺酮预处理在小儿先天性心脏病介入手术中的应用 被引量:2

下载PDF
导出
摘要 目的探讨小剂量氯胺酮预处理对小儿先天性心脏病介入手术不良反应的影响。方法选择择期行介入手术治疗的先天性心脏病患儿40例,随机分为氯胺酮预处理组(K组)和对照组(C组),各20例。氯胺酮预处理组麻醉诱导后肌肉注射氯胺酮1 mg/kg,对照组注射等量生理盐水。比较术中生命体征以及术后躁动、恶心呕吐等不良反应发生率。结果 2组患儿术中生命体征变化比较差异无统计学意义,氯胺酮预处理组术中体动、苏醒期躁动、恶心呕吐等不良反应发生率明显低于对照组(P<0.05)。结论小剂量氯胺酮预处理能够降低小儿先天性心脏病介入手术麻醉后不良反应发生率。
出处 《当代医学》 2016年第32期142-143,共2页 Contemporary Medicine
  • 相关文献

参考文献8

  • 1Odegard KC,Bergersen L,Thiagarajan R,et aI.The Frequency of cardiac arrest9 in patients with congenital heart disease undergoing cardiac catheterization[J].Anesthesia&Analgesia, 2014,118(1):175-182.
  • 2王庚,吴新民.瑞芬太尼复合麻醉患者术后急性阿片类药物耐受的发生[J].中华麻醉学杂志,2007,27(5):389-392. 被引量:88
  • 3Oliver HG,Wilder-Smith OH,L&re Arendt Nielsen. Postoperativehyperalgesia,lts clinical importance and relevance[J]. Anesthesiology, 2006(1 04), 601 -607.
  • 4Pavlin DJ,Horv&th KD,Pavlin EG,et aI.Preincisional treatment to prevent p&in after &mbulatory hernis surgery[J].Anesth Analg, 2003,97(6): 1627-1632.
  • 5解雅英,马正良,曾因明.氯胺酮抗炎作用及机制的研究进展[J].国外医学(麻醉学与复苏分册),2003,24(4):247-250. 被引量:16
  • 6Lankveld DP,Bull S,Vandijk P,et al.Ket&mine inbhibits LPS-induced tumour necrosis f&ctor-alpla and interleukin-6 in an equine macrophage cell line[J].Vet Res,2005(36),257-262.
  • 7Guignaxd B,Coste C,Costes H,et aI.Supplementing desflurane reminfentanil aenathesia with small-does ketamine reduces periopperative opioid analgesic requirements[J]. Anesth Analg, 2002(95): 103-108.
  • 8Salt O,Aoe T,Kozikowski A,et al. Ketamine and N-acetylaspartyl- glutamate peptidase inhibitor exert analgesia in bone cancer pain[J].Can J Anaesth, 2006,53(9), 891-898.

二级参考文献42

  • 1Wanna HT, Gergis SD. Procaine, lidocaine, and ketamine inhibit histamine-induced contracture of guinea pig tracheal muscle in vitro.Anesth Analg, 1978,57:25-27.
  • 2Hirota K, Zsigmond EK, Matsuki A, et al. Topical ketamine inhibits albumin extravasation in chemical peritonitis in rats. Acta Anaesthesiol Seand, 1995,39: 174-178.
  • 3Takenaka I, Ogata M, Koga K, et al. Ketamine suppresses endotoxininduced tumor necrosis factor alpha production in mice. Anesthesiology, 1994,80:402-408.
  • 4Koga K,Ogata M, Takenaka I, et al. Ketamine suppresses tumor necrosis factor-alpha activity and mortality in carrageenan-sensitized endotoxin shock model. Circulatory Shock, 1994,44:160-168.
  • 5Brita L, Gudrun H, Wolfram W, et al. Effect of intravenous anesthetics on spon-lancous and endotoxin-stimullated cytokine response in cultured human whole blood. Anesthesiology, 1998,89:1218-1227.
  • 6Takumi T, Keizo S, Ken Y, et al. Ketamine irahibits endotoxine-induced shock in rats. Anesthesiology,2001 ;95:928.
  • 7Tetra C, Cavaillon JM, Camussi G, et al. Continuous plasma filtration coupled with sorbents. Kidney Int. 1998,66:186-189.
  • 8Roytblat L, Talmor D, Rachinsky M, et al. Ketamine attenuates the intedeukin-6 response after cardiopulmonary bypass. Anesth Analg,1998,87:266-271.
  • 9Kawasaki T, Ogata M, Kawasaki C, et al. Katemine supresses proinflammatory cytokine production in human whole blood in vitro.Anesth Analg, 1999,89:665-669.
  • 10Salo M, Pirttikangas CO, Pulkki K. Effects of propofol emulsion and thiopentone on T helper cell type-1/type-2 balance in vitro. Anaesthesia, 1997,52:341-344.

共引文献102

同被引文献27

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部